{"id":"https://openalex.org/W2592311396","doi":"https://doi.org/10.1186/s12933-017-0511-0","title":"Effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on blood pressure and markers of arterial stiffness in patients with type 2 diabetes mellitus: a post hoc analysis","display_name":"Effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on blood pressure and markers of arterial stiffness in patients with type 2 diabetes mellitus: a post hoc analysis","alternate_titles":[],"publication_year":2017,"publication_date":"2017-02-27","ids":{"openalex":"https://openalex.org/W2592311396","doi":"https://doi.org/10.1186/s12933-017-0511-0","mag":"2592311396","pmid":"https://pubmed.ncbi.nlm.nih.gov/28241822","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5327537"},"language":"en","primary_location":{"id":"doi:10.1186/s12933-017-0511-0","doi":"https://doi.org/10.1186/s12933-017-0511-0","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12933-017-0511-0","pdf_url":"https://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0511-0","source":{"id":"https://openalex.org/S12095120","display_name":"Cardiovascular Diabetology","issn_l":"1475-2840","issn":["1475-2840"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular Diabetology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2592311396"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0511-0","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022776228","display_name":"Michael A. Pfeifer","orcid":"https://orcid.org/0000-0003-1983-5000","observed_orcids":["https://orcid.org/0000-0003-1983-5000"]},"institutions":[{"id":"https://openalex.org/I4391767992","display_name":"Janssen Scientific Affairs (United States)","ror":"https://ror.org/04w4xsz15","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4391767992"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Michael Pfeifer","raw_affiliation_strings":["Janssen Scientific Affairs, LLC, 1125 Trenton-Harbourton Road, Titusville, NJ, 08560, USA. mpfeifer@its.jnj.com","Janssen Scientific Affairs, LLC, 1125 Trenton-Harbourton Road, Titusville, NJ, 08560, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Scientific Affairs, LLC, 1125 Trenton-Harbourton Road, Titusville, NJ, 08560, USA. mpfeifer@its.jnj.com","institution_ids":["https://openalex.org/I4391767992"]},{"raw_affiliation_string":"Janssen Scientific Affairs, LLC, 1125 Trenton-Harbourton Road, Titusville, NJ, 08560, USA","institution_ids":["https://openalex.org/I4391767992"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047317486","display_name":"Raymond R. Townsend","orcid":"https://orcid.org/0000-0002-3215-9118","observed_orcids":["https://orcid.org/0000-0002-3215-9118"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Raymond R. Townsend","raw_affiliation_strings":["Perelman School of Medicine, University of Pennsylvania, 122 Founders Building, 3400 Spruce Street, Philadelphia, PA, 19104, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Perelman School of Medicine, University of Pennsylvania, 122 Founders Building, 3400 Spruce Street, Philadelphia, PA, 19104, USA","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Michael J. Davies","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4391767992","display_name":"Janssen Scientific Affairs (United States)","ror":"https://ror.org/04w4xsz15","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4391767992"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michael J. Davies","raw_affiliation_strings":["Janssen Scientific Affairs, LLC, 1125 Trenton-Harbourton Road, Titusville, NJ, 08560, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Scientific Affairs, LLC, 1125 Trenton-Harbourton Road, Titusville, NJ, 08560, USA","institution_ids":["https://openalex.org/I4391767992"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026752543","display_name":"Ujjwala Vijapurkar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ujjwala Vijapurkar","raw_affiliation_strings":["Janssen Research & Development, LLC, 920 US Highway 202 South, Raritan, NJ, 08869, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Research & Development, LLC, 920 US Highway 202 South, Raritan, NJ, 08869, USA","institution_ids":["https://openalex.org/I4405282460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110531172","display_name":"Jimmy Ren","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4391767992","display_name":"Janssen Scientific Affairs (United States)","ror":"https://ror.org/04w4xsz15","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4391767992"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jimmy Ren","raw_affiliation_strings":["Janssen Scientific Affairs, LLC, 1125 Trenton-Harbourton Road, Titusville, NJ, 08560, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Scientific Affairs, LLC, 1125 Trenton-Harbourton Road, Titusville, NJ, 08560, USA","institution_ids":["https://openalex.org/I4391767992"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5022776228"],"corresponding_institution_ids":["https://openalex.org/I4391767992"],"apc_list":{"value":4290,"currency":"USD","value_usd":4290},"apc_paid":{"value":4290,"currency":"USD","value_usd":4290},"fwci":8.7495,"has_fulltext":true,"cited_by_count":142,"citation_normalized_percentile":{"value":0.98703886,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":100},"biblio":{"volume":"16","issue":"1","first_page":"29","last_page":"29"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.7519999742507935,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.7519999742507935,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.22349999845027924,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10821","display_name":"Cardiovascular Function and Risk Factors","score":0.005799999926239252,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/canagliflozin","display_name":"canagliflozin","score":0.9959999918937683},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.972000002861023},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9890000224113464},{"id":"https://openalex.org/keywords/blood-pressure","display_name":"blood pressure","score":0.8650000095367432},{"id":"https://openalex.org/keywords/arterial-stiffness","display_name":"arterial stiffness","score":0.9350000023841858},{"id":"https://openalex.org/keywords/pulse-pressure","display_name":"pulse pressure","score":0.9959999918937683},{"id":"https://openalex.org/keywords/mean-arterial-pressure","display_name":"mean arterial pressure","score":0.9990000128746033},{"id":"https://openalex.org/keywords/rate-pressure-product","display_name":"rate-pressure product","score":0.7329999804496765},{"id":"https://openalex.org/keywords/ambulatory-blood-pressure-monitoring","display_name":"ambulatory blood pressure monitoring","score":0.9639999866485596},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.7990000247955322},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.6650000214576721},{"id":"https://openalex.org/keywords/antihypertensive-effect","display_name":"antihypertensive effect","score":0.5950000286102295},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.656000018119812},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.44600000977516174},{"id":"https://openalex.org/keywords/dose-comparison","display_name":"dose comparison","score":0.4580000042915344},{"id":"https://openalex.org/keywords/ambulatory-blood-pressure","display_name":"ambulatory blood pressure","score":0.9229999780654907}],"concepts":[{"id":"https://openalex.org/C2777451236","wikidata":"https://www.wikidata.org/wiki/Q5030940","display_name":"Canagliflozin","level":4,"score":0.9286762475967407},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8266165256500244},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.7198631167411804},{"id":"https://openalex.org/C17140001","wikidata":"https://www.wikidata.org/wiki/Q1759415","display_name":"Pulse pressure","level":3,"score":0.6425391435623169},{"id":"https://openalex.org/C67761136","wikidata":"https://www.wikidata.org/wiki/Q2105849","display_name":"Post-hoc analysis","level":2,"score":0.6029993295669556},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.580778181552887},{"id":"https://openalex.org/C2775850156","wikidata":"https://www.wikidata.org/wiki/Q4797538","display_name":"Arterial stiffness","level":3,"score":0.555758535861969},{"id":"https://openalex.org/C2776452961","wikidata":"https://www.wikidata.org/wiki/Q1940733","display_name":"Mean arterial pressure","level":4,"score":0.5297920107841492},{"id":"https://openalex.org/C149323552","wikidata":"https://www.wikidata.org/wiki/Q3090739","display_name":"Ambulatory blood pressure","level":3,"score":0.5268099308013916},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.48315972089767456},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.4540255665779114},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.4267823100090027},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.42193466424942017},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.41750431060791016},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3723607659339905},{"id":"https://openalex.org/C2777953023","wikidata":"https://www.wikidata.org/wiki/Q1073121","display_name":"Heart rate","level":3,"score":0.13957804441452026},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068896","descriptor_name":"Canagliflozin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000068896","descriptor_name":"Canagliflozin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000077203","descriptor_name":"Sodium-Glucose Transporter 2 Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007687","descriptor_name":"Kidney Tubules, Proximal","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D007687","descriptor_name":"Kidney Tubules, Proximal","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018660","descriptor_name":"Blood Pressure Monitoring, Ambulatory","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051297","descriptor_name":"Sodium-Glucose Transporter 2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D059289","descriptor_name":"Vascular Stiffness","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1186/s12933-017-0511-0","doi":"https://doi.org/10.1186/s12933-017-0511-0","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12933-017-0511-0","pdf_url":"https://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0511-0","source":{"id":"https://openalex.org/S12095120","display_name":"Cardiovascular Diabetology","issn_l":"1475-2840","issn":["1475-2840"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular Diabetology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:5327537","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5327537/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovasc Diabetol","raw_type":"Text"},{"id":"pmid:28241822","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28241822","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular diabetology","raw_type":"Clinical Trial, Phase III"},{"id":"mag:3190956685","doi":null,"is_oa":false,"landing_page_url":"https://jglobal.jst.go.jp/detail?JGLOBAL_ID=201802223969310663","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":{"id":"doi:10.1186/s12933-017-0511-0","doi":"https://doi.org/10.1186/s12933-017-0511-0","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12933-017-0511-0","pdf_url":"https://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0511-0","source":{"id":"https://openalex.org/S12095120","display_name":"Cardiovascular Diabetology","issn_l":"1475-2840","issn":["1475-2840"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular Diabetology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320317188","display_name":"Janssen Scientific Affairs","ror":"https://ror.org/04w4xsz15"},{"id":"https://openalex.org/F4320327566","display_name":"Mitsubishi Tanabe Pharma Corporation","ror":"https://ror.org/038ehsm73"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2592311396.pdf","grobid_xml":"https://content.openalex.org/works/W2592311396.grobid-xml"},"referenced_works_count":39,"referenced_works":["https://openalex.org/W122349615","https://openalex.org/W1511683349","https://openalex.org/W1709919176","https://openalex.org/W1835375518","https://openalex.org/W1981671332","https://openalex.org/W1982905493","https://openalex.org/W1997018189","https://openalex.org/W2024878386","https://openalex.org/W2029714169","https://openalex.org/W2047553605","https://openalex.org/W2058375005","https://openalex.org/W2059158127","https://openalex.org/W2060411911","https://openalex.org/W2067804264","https://openalex.org/W2068171948","https://openalex.org/W2074989651","https://openalex.org/W2084511068","https://openalex.org/W2097980954","https://openalex.org/W2108314801","https://openalex.org/W2114250030","https://openalex.org/W2134304394","https://openalex.org/W2135097670","https://openalex.org/W2146264128","https://openalex.org/W2150411515","https://openalex.org/W2164782732","https://openalex.org/W2167984652","https://openalex.org/W2168926920","https://openalex.org/W2194668499","https://openalex.org/W2284028653","https://openalex.org/W2301210108","https://openalex.org/W2341643234","https://openalex.org/W2343975335","https://openalex.org/W2442314529","https://openalex.org/W2470197143","https://openalex.org/W2510990897","https://openalex.org/W2550194700","https://openalex.org/W2556842465","https://openalex.org/W3021572394","https://openalex.org/W4231460044"],"related_works":["https://openalex.org/W2808972260","https://openalex.org/W4411868130","https://openalex.org/W1981671332","https://openalex.org/W3106228356","https://openalex.org/W2806947749","https://openalex.org/W1223180826","https://openalex.org/W2887770654","https://openalex.org/W3033903535","https://openalex.org/W3153432852","https://openalex.org/W2018309807"],"abstract_inverted_index":{"BACKGROUND:":[0],"Physiologic":[1],"determinants,":[2],"such":[3],"as":[4],"pulse":[5,51,123,187,264],"pressure":[6,11,19,188,197,265,273],"[difference":[7],"between":[8],"systolic":[9],"blood":[10],"(SBP)":[12],"and":[13,25,56,95,112,128,161,167,172,175,190,199,204,208,221,232,240,245,248,270],"diastolic":[14],"BP":[15,102,135,142],"(DBP)],":[16],"mean":[17,53,125,195,236,271],"arterial":[18,54,126,196,272],"(2/3":[20],"DBP":[21,173,246],"+":[22],"1/3":[23],"SBP),":[24],"double":[26,57,129,205],"product":[27,58,130,206],"[beats":[28],"per":[29],"minute":[30],"(bpm)":[31],"\u00d7":[32,213],"SBP],":[33],"are":[34],"linked":[35],"to":[36],"cardiovascular":[37,306,321],"outcomes.":[38],"The":[39],"effects":[40,288,318],"of":[41],"canagliflozin,":[42],"a":[43,96],"sodium":[44],"glucose":[45],"co-transporter":[46],"2":[47,65],"(SGLT2)":[48],"inhibitor,":[49],"on":[50,76,150,289,319],"pressure,":[52,55,124,127],"were":[59,131,215],"assessed":[60,132,148],"in":[61,88,108,120,186,263,297,323],"patients":[62,89,109,324],"with":[63,90,110,218,279,310,325],"type":[64],"diabetes":[66],"mellitus":[67],"(T2DM).":[68],"METHODS:":[69],"This":[70],"post":[71],"hoc":[72],"analysis":[73],"was":[74,147,293],"based":[75,149],"pooled":[77,157],"data":[78],"from":[79,118],"four":[80],"26-week,":[81],"randomized,":[82,98],"double-blind,":[83,99],"placebo-controlled":[84],"studies":[85],"evaluating":[86,106],"canagliflozin":[87,107,159,219,230,282,314],"T2DM":[91,111],"(N":[92,114],"=":[93,115],"2313)":[94],"6-week,":[97],"placebo-controlled,":[100],"ambulatory":[101],"monitoring":[103],"(ABPM)":[104],"study":[105,299],"hypertension":[113],"169).":[116],"Changes":[117],"baseline":[119],"SBP,":[121],"DBP,":[122],"using":[133],"seated":[134],"measurements":[136],"(pooled":[137],"studies)":[138],"or":[139],"averaged":[140],"24-h":[141,237],"assessments":[143],"(ABPM":[144],"study).":[145],"Safety":[146],"adverse":[151],"event":[152],"reports.":[153],"RESULTS:":[154],"In":[155,226],"the":[156,227,311],"studies,":[158],"100":[160,220,231,283],"300":[162,222,233,259],"mg":[163,223,234,260,284],"reduced":[164,235],"SBP":[165,238],"(-4.3":[166],"-5.0":[168],"vs":[169,177,192,201,210,242,250,267,275],"-0.3":[170,251],"mmHg)":[171,179,214,244,252,269,277],"(-2.5":[174],"-2.4":[176],"-0.6":[178,276],"versus":[180,224,253],"placebo":[181,254],"at":[182,255],"week":[183,256],"26.":[184],"Reductions":[185],"(-1.8":[189],"-2.6":[191],"0.2":[193],"mmHg),":[194,203],"(-3.1":[198],"-3.3":[200],"-0.5":[202],"(-381":[207],"-416":[209],"-30":[211],"bpm":[212],"also":[216],"seen":[217],"placebo.":[225],"ABPM":[228],"study,":[229],"(-4.5":[239],"-6.2":[241],"-1.2":[243],"(-2.2":[247],"-3.2":[249],"6.":[257],"Canagliflozin":[258,292,302],"provided":[261],"reductions":[262],"(-3.3":[266],"-0.8":[268],"(-4.2":[274],"compared":[278],"placebo,":[280],"while":[281],"had":[285],"more":[286],"modest":[287],"these":[290],"parameters.":[291],"generally":[294],"well":[295],"tolerated":[296],"both":[298],"populations.":[300],"CONCLUSIONS:":[301],"improved":[303],"all":[304],"three":[305],"physiologic":[307],"markers,":[308],"consistent":[309],"hypothesis":[312],"that":[313],"may":[315],"have":[316],"beneficial":[317],"some":[320],"outcomes":[322],"T2DM.":[326],"Trial":[327],"registration":[328],"ClinicalTrials.gov":[329],"Identifier:":[330],"NCT01081834":[331],"(registered":[332,336,340,344,348],"March":[333],"2010);":[334,338,342,346],"NCT01106677":[335],"April":[337,341,345],"NCT01106625":[339],"NCT01106690":[343],"NCT01939496":[347],"September":[349],"2013).":[350]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2592311396","counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":16},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":16},{"year":2022,"cited_by_count":19},{"year":2021,"cited_by_count":26},{"year":2020,"cited_by_count":15},{"year":2019,"cited_by_count":17},{"year":2018,"cited_by_count":15},{"year":2017,"cited_by_count":3}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2017-03-16T00:00:00"}
